Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

Cited In for PubMed (Select 8285810)


Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.

Norris SL, Holmer HK, Ogden LA, Burda BU, Fu R.

PLoS One. 2013 Oct 14;8(10):e75284. doi: 10.1371/journal.pone.0075284. eCollection 2013.


SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D.

BMJ. 2013 Jan 8;346:e7586. doi: 10.1136/bmj.e7586.


Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse.

Norris SL, Holmer HK, Ogden LA, Selph SS, Fu R.

PLoS One. 2012;7(11):e47343. doi: 10.1371/journal.pone.0047343. Epub 2012 Nov 7. Erratum in: PLoS One. 2013;8(8). doi:10.1371/annotation/1b125769-1f74-4225-94b8-bd2c80adae1f.


Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.

Dickersin K, Chalmers I.

J R Soc Med. 2011 Dec;104(12):532-8. doi: 10.1258/jrsm.2011.11k042. No abstract available. Erratum in: J R Soc Med. 2012 Mar;105(3):96.


Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature.

Bailey CS, Fehlings MG, Rampersaud YR, Hall H, Wai EK, Fisher CG.

Can J Surg. 2011 Oct;54(5):321-6. doi: 10.1503/cjs.008610. Review.


Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.

Montedori A, Bonacini MI, Casazza G, Luchetta ML, Duca P, Cozzolino F, Abraha I.

Trials. 2011 Feb 28;12:58. doi: 10.1186/1745-6215-12-58.


The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig WD, Lieb K.

Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23. Review.


Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.

Rose SL, Krzyzanowska MK, Joffe S.

J Clin Oncol. 2010 Mar 10;28(8):1316-21. doi: 10.1200/JCO.2008.21.6606. Epub 2010 Jan 11.


Association of trial registration with the results and conclusions of published trials of new oncology drugs.

Rasmussen N, Lee K, Bero L.

Trials. 2009 Dec 16;10:116. doi: 10.1186/1745-6215-10-116.


Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative study.

Cavazos JM, Naik AD, Woofter A, Abraham NS.

Aliment Pharmacol Ther. 2008 Sep 15;28(6):789-98.


Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.

Rising K, Bacchetti P, Bero L.

PLoS Med. 2008 Nov 25;5(11):e217; discussion e217. doi: 10.1371/journal.pmed.0050217. Erratum in: PLoS Med. 2009 Jan;6(1). doi: 10.1371/journal.Pmed.1000017.


Evolution of the randomized controlled trial in oncology over three decades.

Booth CM, Cescon DW, Wang L, Tannock IF, Krzyzanowska MK.

J Clin Oncol. 2008 Nov 20;26(33):5458-64. doi: 10.1200/JCO.2008.16.5456. Epub 2008 Oct 27.


Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions.

Jørgensen AW, Maric KL, Tendal B, Faurschou A, Gøtzsche PC.

BMC Med Res Methodol. 2008 Sep 9;8:60. doi: 10.1186/1471-2288-8-60.


Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?

Golder S, Loke YK.

Br J Clin Pharmacol. 2008 Dec;66(6):767-73. doi: 10.1111/j.1365-2125.2008.03272.x. Epub 2008 Jul 31. Review.


Abstracts in high profile journals often fail to report harm.

Bernal-Delgado E, Fisher ES.

BMC Med Res Methodol. 2008 Mar 27;8:14. doi: 10.1186/1471-2288-8-14. Review.


Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review.

Jørgensen AW, Hilden J, Gøtzsche PC.

BMJ. 2006 Oct 14;333(7572):782. Epub 2006 Oct 6. Review.


Medical journals are an extension of the marketing arm of pharmaceutical companies.

Smith R.

PLoS Med. 2005 May;2(5):e138. Epub 2005 May 17. No abstract available.


The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.

Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D.

BMJ. 2004 Oct 23;329(7472):948. Epub 2004 Oct 8. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk